Indian company develops country’s first HPV vaccine
The Serum Institute of India (SII), the world’s biggest vaccine maker, has developed the country’s first cervical cancer shot that will hit the market within a few months.
Public health & disease
Scientists hail autoimmune disease therapy breakthrough
A new treatment from Friedrich-Alexander University in Germany drove the disease into remission in all of its five patients, who have now been off lupus medication for between three and 17 months.
Scientists achieve the impossible, safely destroy toxic ‘forever chemicals’
Even low-level exposure to these chemicals over a sustained amount of time can lead to serious health effects, including thyroid disease, reduced immune response, and several cancers.
Togo achieves ‘major feat’ of eliminating four neglected tropical diseases
The WHO has hailed the west African country as first in world to stamp out Guinea worm, lymphatic filariasis, sleeping sickness and trachoma
New study offers hope that pill can cut hereditary cancer risk by 60 percent
The double-blind longitudinal study followed nearly 1,000 patients with Lynch Syndrome, an inherited genetic condition that increases the individual risk of several cancers, for almost 20 years.
New sensor detects Alzheimer’s up to 17 years in advance
The Bochum researchers hope that an early diagnosis based on the amyloid-beta misfolding could help to apply Alzheimer’s drugs at such an early stage that they have a significantly better effect.
Botswana reduces mother-baby HIV transmission rates from 40% to below 1% since 1999
Botswana has became the first high-burden country to receive the WHO’s silver tier award for its efforts to cut child transmission rates.
In world first, The Netherlands caps flights at major airport to cut pollution
The new policy, set to take effect at the end of 2023, is the world’s first to limit flights for environmental reasons.
Revolutionary new photoimmunotherapy lights up and wipes out cancer cells
Experts are predicting that this new photoimmunotherapy will be the world’s fifth major cancer treatment following surgery, chemotherapy, radiotherapy, and immunotherapy.
U.S. FDA approves first alopecia drug that restores hair growth in many patients
It is the first approved treatment for alopecia areata, an autoimmune disorder that affects about 7 million people in the United States.